Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group.
Schornagel JH, Verweij J, de Mulder PH, Cognetti F, Vermorken JB, Cappelaere P, Armand JP, Wildiers J, Clavel M, Kirkpatrick A, et al. Schornagel JH, et al. Among authors: cappelaere p. Ann Oncol. 1992 Mar;3(3):223-6. doi: 10.1093/oxfordjournals.annonc.a058156. Ann Oncol. 1992. PMID: 1586620 Free article. Clinical Trial.
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
Schornagel JH, Verweij J, de Mulder PH, Cognetti F, Vermorken JB, Cappelaere P, Armand JP, Wildiers J, de Graeff A, Clavel M, et al. Schornagel JH, et al. Among authors: cappelaere p. J Clin Oncol. 1995 Jul;13(7):1649-55. doi: 10.1200/JCO.1995.13.7.1649. J Clin Oncol. 1995. PMID: 7602354 Free article. Clinical Trial.
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
Clavel M, Vermorken JB, Cognetti F, Cappelaere P, de Mulder PH, Schornagel JH, Tueni EA, Verweij J, Wildiers J, Clerico M, et al. Clavel M, et al. Among authors: cappelaere p. Ann Oncol. 1994 Jul;5(6):521-6. doi: 10.1093/oxfordjournals.annonc.a058906. Ann Oncol. 1994. PMID: 7522527 Free article. Clinical Trial.
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Degardin M, Oliveira J, Geoffrois L, Rolland F, Armand JP, Bastit P, Chauvergne J, Fargeot P, van Glabbeke M, Lentz MA, Tresca P, Boudillet J, Fumoleau P, Cappelaere P. Degardin M, et al. Among authors: cappelaere p. Ann Oncol. 1998 Oct;9(10):1103-7. doi: 10.1023/a:1008446706578. Ann Oncol. 1998. PMID: 9834823 Free article. Clinical Trial.
An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
De Jager R, Cappelaere P, Armand JP, Keiling R, Fargeot P, Bastit P, van Glabbeke M, Renard J, Earl H, Rubens R, et al. De Jager R, et al. Among authors: cappelaere p. Eur J Cancer Clin Oncol. 1984 Nov;20(11):1369-75. doi: 10.1016/0277-5379(84)90055-5. Eur J Cancer Clin Oncol. 1984. PMID: 6542006
Phase II clinical evaluation of 4'-epi-doxorubicin.
Hurteloup P, Cappelaere P, Armand JP, Mathé G. Hurteloup P, et al. Among authors: cappelaere p. Cancer Treat Rep. 1983 Apr;67(4):337-41. Cancer Treat Rep. 1983. PMID: 6573956
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC).
Chauvergne J, Fumoleau P, Cappelaere P, Metz R, Armand JP, Chevallier B, Kerbrat P, de Forni M, Lhommé C, Roche H, et al. Chauvergne J, et al. Among authors: cappelaere p. Eur J Cancer. 1993;29A(3):350-4. doi: 10.1016/0959-8049(93)90384-r. Eur J Cancer. 1993. PMID: 8398333 Clinical Trial.
148 results